Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - Cogent Biosciences, Inc. | umrx-ex322_7.htm |
| EX-32.1 - EX-32.1 - Cogent Biosciences, Inc. | umrx-ex321_6.htm |
| EX-31.2 - EX-31.2 - Cogent Biosciences, Inc. | umrx-ex312_8.htm |
| EX-31.1 - EX-31.1 - Cogent Biosciences, Inc. | umrx-ex311_9.htm |
| EX-4.3 - EX-4.3 - Cogent Biosciences, Inc. | umrx-ex43_326.htm |
| 10-K - 10-K - Cogent Biosciences, Inc. | umrx-10k_20191231.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (No. 333-224137 and No. 333-230559) and Form S-3 (No. 333-230678) of Unum Therapeutics Inc. of our report dated March 26, 2020 relating to the financial statements, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
March 26, 2020